Total Health Enhancment products supports human health function

With a range of effective products and the ability to expand into new markets, Total Health is prepared to capitalize on this niche. Total Health formulates products as a result of market need rather than what they believe to be great products; thus providing products with a ready demand. Then, using methodologies based on the proprietary Neurotransmitter Production Support Technology (N.P.S.) and data gathered from international medical literature, Total Health formulates a product, designs and performs scientific studies to (biochemical, physiologic, clinical, placebo controlled double blind trials) validate this product.

Total Health has worked within the Clinical Medical Foods environment for a number of years and has recently begun to gain momentum for 'Over-the-Counter' products. Concurrently, an opportunity within the Equine marketplace appeared where product sales are gaining momentum. It is this market that Total Health chose to target first due to the low barrier to entry for their product; no lengthy efficacy trials as is the case with human products.

The principal intellectual property of Total Health is "Neurotransmitter Production Support" (N.P.S.), a 'platform technology' that allows common amino acids, the building blocks of the body, to operate at doses 2%-5% of what was previously thought possible. Amino acids are the 'feedstocks' from which the body produces neurotransmitters. Neurotransmitters govern virtually all functions of the body. Therefore the N.P.S. technology has immense potential in both human and animal nutrition as well as disease treatment.

In the United States alone, there are over 6.9 million horses and an $8 billion market products for equine health. Total Health has a tremendous opportunity in this area. Total Health has also ventured into developing similar products for dogs, cats, livestock, and zoo animals.

The human market potential is significantly greater, but has higher product development and marketing costs. Initial products developed for Humans have performed well beyond expectations. The market in the United States for nutritional products alone exceeds $52 billion.

One of Total Health's unique advantages is to identify a demand for a product and develop a marketable commodity in a very short period of time. In the pharmaceutical industry it typically takes over 7 years from the time a drug is formulated until it is approved for animal use. Conventional approaches to developing a new drug for animals cost tens of millions of dollars before it can be offered for sale.

All existing competitive products are more dangerous (particularly pharmaceuticals using receptor technology), more expensive (because of the large quantities of active elements required due to the absence of N.P.S.) or less effective. In some cases (e.g.: serotonin production without tryptophan) there is no known way to accomplish the effect without N.P.S. patent protected elements. As long as Total Health's N.P.S. system remains protected Total Health has the opportunity to obtain and hold a strong market share.